Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q8IXL6 (
RNS
)
1,091
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ischemia/reperfusion (I/R) injury induces post-translational modifications of myosin light chains (MLCs), increasing their susceptibility to degradation by matrix metalloproteinase 2 (MMP-2). This results in the degradation of ventricular light chains (
VLC1
) in heart ventricles. The aim of the study was to investigate changes in MLCs content in the mechanism of adaptation to oxidative stress during I/R. Rat hearts, perfused using the Langendorff method, were subjected to I/R. The control group was maintained in oxygen conditions. Lactate dehydrogenase (LDH) activity and reactive oxygen/nitrogen species (ROS/
RNS
) content were measured in coronary effluents. Atrial light chains (ALC1) and ventricular light chains (
VLC1
) gene expression were examined using RQ-PCR. ALC1 and
VLC1
protein content were measured using ELISA tests. MMP-2 activity was assessed by zymography. LDH activity as well as ROS/
RNS
content in coronary effluents was higher in the I/R group (
p
= 0.01,
p
= 0.04, respectively), confirming heart injury due to increased oxidative stress. MMP-2 activity in heart homogenates was also higher in the I/R group (
p
= 0.04). ALC1 gene expression and protein synthesis were significantly increased in I/R ventricles (
p
< 0.01, 0.04, respectively).
VLC1
content in coronary effluents was increased in the I/R group (
p
= 0.02), confirming the increased degradation of
VLC1
by MMP-2 and probably an adaptive production of ALC1 during I/R. This mechanism of adaptation to oxidative stress led to improved heart mechanical function.
...
PMID:Tissue Expression of Atrial and Ventricular Myosin Light Chains in the Mechanism of Adaptation to Oxidative Stress. 3318 31